Erector Spinae Plane Block: For Pain Control in Patients Undergoing Flank Incision



Status:Enrolling by invitation
Conditions:Nephrology
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - 85
Updated:11/8/2018
Start Date:September 28, 2018
End Date:February 28, 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Erector Spinae Plane Block (ESPB): A New Technique for Perioperative Pain Control in Patients Undergoing Surgery Through a Flank Incision.

Using a randomized double-blinded study design, the study goal is to evaluate the superiority
of Erector Spinae Plane block (ESPB) in the peri-operative pain management of patients
undergoing surgery through a flank incision as compared to the standard of care of using IV
and oral opiates.

40 subjects will be randomized in to 2 groups, with 20 in each group.

- Group 1. Erector spinae plane block (ESPB) (containing Ropivacaine)

- Group 2. Sham Erector spinae plane block. (SESPB) (with normal saline)

Inclusion Criteria:

- Consenting adults age 18-85

- American Society of Anesthesiologists (ASA) Physical Status classification I to III

- Planned to be hospitalized for at least 24 hours post-op

- Cognitive capacity to use the visual analogic scale (VAS) and complete the patient
satisfaction survey

Exclusion Criteria:

- Patient refusal

- Patients with allergies to local anesthetics or opiates (hydromorphone or oxycodone)

- Scoliosis

- Patients with chronic pain syndromes or who are on chronic pain medications/other
neurologic medication of more than 3 months or whom have neuromodulators/stimulators

- Concurrent surgeries requiring additional incisions on the body
We found this trial at
1
site
The Milton S. Hershey Medical Center
Hershey, Pennsylvania 17033
?
mi
from
Hershey, PA
Click here to add this to my saved trials